Companies: 10,795·Total market cap: $144.5T
Cytek Biosciences, Inc.

Cytek Biosciences, Inc.

CTKBNASDAQHealthcare● Active
$4.05
$-0.04(-1.05%)
Market Cap$522640050
P/E Ratio
52W High$6.18
52W Low$2.9
Overview

Cytek Biosciences, Inc. (CTKB) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · CTKB · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-0.58ctkb eps ttm · ctkb earnings per shareEarnings history
PE Ratio (TTM)ctkb pe ratio ttm · ctkb price to earningsPE Ratio deep dive
Revenue (TTM)$204.2Mctkb revenue ttm · ctkb annual revenueFull revenue history
Dividend YieldNo Dividenddoes ctkb pay dividends · ctkb dividend yieldDividend history
Shares Outstanding127.7Mctkb shares outstanding · ctkb floatShares outstanding history
Next EarningsAug 5, 2026Est.ctkb earnings date · ctkb next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$201.5M▲ +0.52% YoY
202320242025
cytek biosciences, inc. revenue · ctkb revenue 2025
FY 2025Net Income-$66.5M▼ 1005.30% YoY
202320242025
cytek biosciences, inc. net income · ctkb profit 2025
FY 2025EPS$-0.52▼ 1030.43% YoY
202320242025
ctkb eps · cytek biosciences, inc. earnings per share 2025
TTM:Revenue: $204.2MNet Income: -$74.0MEPS: $-0.58View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy5 analystsis ctkb a buy · ctkb analyst rating
Strong Buy
0
Buy
3
Hold
1
Sell
1
Strong Sell
0
12-Month Price Target
$4.75Low
$4.05Current
$5.13Avg Target26.76% upside
$5.50High
ctkb price target · ctkb 12 month forecast

Total: 5 · Buy rate: 60.0%

The CTKB analyst consensus is Buy, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $5.13, representing +26.76% upside from the current price of $4.05.

Stock Performance

Full History
1D-5.54%
1W-2.39%
1M-11.28%
3M-3.08%
YTD-19.01%
1Y+14.89%
5Y-78.20%

About Cytek Biosciences, Inc.

CEOWenbin Jiang
IPO DateJul 23, 2021
Employees663
CountryUS

Cytek Biosciences, Inc. a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and nor…

what is cytek biosciences, inc. · ctkb stock overview · cytek biosciences, inc. company profile · who is cytek biosciences, inc. ceo · ctkb NASDAQ · cytek biosciences, inc. headquarters · cytek biosciences, inc. business segments

About Stock Overview & Key Data

Cytek Biosciences, Inc. (CTKB) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Jul 23, 2021. As of the latest trading session, CTKB stock price is $4.05, with a market capitalization of $522.6M. The stock has returned +14.89% over the past 12 months and -19.01% year-to-date.

According to 5 Wall Street analysts, the consensus rating for Cytek Biosciences, Inc. stock is Buy, with an average 12-month price target of $5.13. In fiscal year 2025, Cytek Biosciences, Inc. reported revenue of $201.5M and net income of -$66.5M. For detailed data — including Cytek Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Cytek Biosciences, Inc. (CTKB) stock price is $4.05. The stock is traded on NASDAQ under the ticker symbol CTKB. The 52-week range is $2.90 – $6.18.

CTKB stock priceCTKB quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice